Horizon Kinetics Medical ETF
NASDAQ:MEDX

  • LAST PRICE
    27.16
  • TODAY'S CHANGE (%)
    -0.85 (-3.04%)
  • Bid / Lots
    24.85/ 1
  • Ask / Lots
    30.13/ 1
  • Open / Previous Close
    28.01 / 28.01
  • Day Range
    27.16
    28.01
  • 52 Week Range
    27.16
    32.00
  • Volume
    1,634
  • Overall Morningstar Rating
    out of 268 funds

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Daily Premium/Discount

Bar Graph.See accessible table below
ETFs trading at a price higher than its Net Asset Value (NAV) is said to be trading at a premium, while those trading at price lower than its NAV is said to be at a discount. By showing the daily premium/discount percentage, we can see the trend in market sentiments, regarding the value of an ETF over time.

Holdings Diversification

Asset Class
US Stock		74.5%
Non-US Stock		19.6%
Cash		5.9%
Convertible		0
Non-US Bond		0
Other		0
Sectors
Healthcare94.1%
Basic Mat.0
Communication Services0
Consumer Cyclical0
Consumer Defensive0
Energy0
Financial Serv.s0
Industrials0
Real Estate0
Technology0
Utilities0
Geographic Region
United States		79.2%
Europe		0.1%
Latin America		0
Africa		0
Canada		0
Asia/Oceania		0
As of 2024-10-31

Top 10 Holdings

Company NamePositionAllocation
Allocation
1 Month Change
Market Value
LLY
Eli Lilly and Co
Long
16.0%
0.00%
$2.7M
ABBV
AbbVie Inc
Long
9.0%
0.00%
$1.5M
AMGN
Amgen Inc
Long
6.2%
0.00%
$1.0M
NVS
Novartis AG ADR
Long
6.0%
0.00%
$996.6K
BMY
Bristol-Myers Squibb Co
Long
5.7%
0.00%
$948.6K
AZN
AstraZeneca PLC ADR
Long
5.1%
0.00%
$850.4K
JNJ
Johnson & Johnson
Long
4.7%
0.00%
$782.2K
ALNY
Alnylam Pharmaceuticals Inc
Long
4.4%
0.00%
$735.5K
PFE
Pfizer Inc
Long
4.2%
0.00%
$702.5K
MRK
Merck & Co Inc
Long
4.0%
0.00%
$658.5K
As of 2024-11-11

Reports

  • 04/07/24

    Morningstar ETF Report

    The Morningstar ETF Report offers in-depth analyst research on exchange-traded funds to help you evaluate these investments and how they fit within a portfolio.

Morningstar Ratings

Time HorizonStar Rating
Overall Rating
3 Year Rating
5 Year Rating
10 Year Rating
As of 2024-10-31

Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.

Style Box is calculated only using the long position holdings of the portfolio.

ETF Profile
Best Fit Index
S&P 500 TR USD
Category
Health
Sponsor
Horizon Kinetics Asset Management LLC
Inception
September 30, 1999
As of 2024-10-31

The investment seeks to provide long-term growth of capital. The fund is an actively-managed exchange-traded fund (“ETF”) that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.

Holding Details
Total Net Assets$16.7M
Shares Out.570.0K
Net Asset Value (NAV)$27.16
Prem/Discount to NAV0.01%
P/E Ratio29.6
Dividend Yield1.49%
Dividend per Share0.40 USD
Ex-Dividend Date12/27/2023
Dividend Payment Date12/29/2023
Beta---
Morningstar Investment StyleHealth
Equity Style
Large Cap Blend
Credit Quality / Duration
---
Fees & Expenses
Actual Management Fee0.85%
Actual Mgmt. Expense Ratio (MER)0.85%